Dr Anthony Hugh Morgan, DPM in Colchester, CT - Medicare Provider

Dr Anthony Hugh Morgan, DPM is a medicare enrolled "Podiatrist" provider in Colchester, Connecticut. His current practice location is 7 Park Ave, Colchester, Connecticut. You can reach out to his office (for appointments etc.) via phone at (860) 537-5520.

Dr Anthony Hugh Morgan is licensed to practice in Connecticut (license number 000718) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1073593307.

Contact Information

	Dr Anthony Hugh Morgan, DPM
	7 Park Ave, Colchester, CT 06415-1128
	(860) 537-5520
	(860) 537-5590

Healthcare Provider's Profile

Full Name	Dr Anthony Hugh Morgan
Gender	Male
Speciality
Experience	Years
Location	7 Park Ave, Colchester, Connecticut
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Anthony Hugh Morgan attended and graduated from in

NPI Data:

NPI Number: 1073593307
Provider Enumeration Date: 01/20/2006
Last Update Date: 10/09/2008

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Dr Anthony Hugh Morgan such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1073593307	NPI	-	NPPES
004204616	Medicaid	CT

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
213E00000X	Podiatrist	000718 (Connecticut)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Anthony Hugh Morgan is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Anthony Hugh Morgan, DPM 7 Park Ave, Colchester, CT 06415-1128 Ph: (860) 537-5520	Dr Anthony Hugh Morgan, DPM 7 Park Ave, Colchester, CT 06415-1128 Ph: (860) 537-5520

News Archive

New analogues effective in inhibiting NOS activity in Parkinson models

University of Granada researchers have tested melatonin analogues in rats as it inhibits the enzyme nitric oxide synthase (NOS), which is involved in the development of conditions as inflammatory bowel disease, septic shock or rheumatoid arthritis, as well as in neurodegenerative conditions as Huntington's disease, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.

Male hormone testosterone may increase risk of colon cancer

Previous cancer research has revealed that women are less likely than men to suffer from non-sex specific cancers such as cancer of the colon, pancreas and stomach. Scientists theorized that perhaps this trend was due to a protecting effect created by female hormones, such as estrogen, that help prevent tumors from forming. Now, researchers at the University of Missouri have found evidence suggesting that the male hormone testosterone may actually be a contributing factor in the formation of colon cancer tumors.

Centris selects CA Service Desk Manager to provide quality customer support

The leading Swiss IT service provider for health and accident insurers, Centris AG, based in Solothurnsupports around 4,500 users in 28 companies to manage in excess of 1.5 million insured persons. An important element of the service portfolio of Centris, is the "Swiss Health Platform" (SHP), which is used by approximately 1,000 users. The quality of the customer support provided by Centris is the make or break factor for the competitiveness of this complex platform.

FDA accepts Pain Therapeutics NDA resubmission for REMOXY

Pain Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) resubmission for REMOXY (controlled-release oxycodone) and has classified it as a Class 2 resubmission.

Dr Anthony Hugh Morgan, DPM - Medicare Podiatrist in Colchester, CT